Most recent vaccine to seasonal influenza ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
13Multiple sclerosis/Neuromyelitis optica1

13. Multiple sclerosis/Neuromyelitis optica


Clinical trials : 3,340 Drugs : 2,163 - (DrugBank : 383) / Drug target genes : 241 - Drug target pathways : 238
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05019248
(ClinicalTrials.gov)
September 1, 202019/8/2021Immune Response to Seasonal Influenza Vaccination in Multiple Sclerosis Patients Receiving CladribineA Non-interventional Observation Study to Evaluate Immune Responses Following Seasonal Influenza Vaccine in Participants With Relapsing Multiple Sclerosis Treated With Cladribine TabletsMultiple Sclerosis, Relapsing-Remitting;Vaccine Response ImpairedBiological: Most recent vaccine to seasonal influenzaHeinrich-Heine University, DuesseldorfNULLRecruiting18 Years60 YearsAll260Germany